In VivoStudies of Adenovirus-Based p53 Gene Therapy for Ovarian Cancer

By von Gruenigen V.E.   Santoso J.T.   Coleman R.L.   Muller C.Y.   Miller D.S.   Mathis J.M.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 197-204

Elsevier

Access to resources Recommend Favorite

Adenovirus-Based p53 Gene Therapy in Ovarian Cancer

By Santoso J.T.   Tang D-C.   Lane S.B.   Hung J.   Reed D.J.   Muller C.Y.   Carbone D.P.   Lucci II. J.A.   Scott Miller D.   Mathis M.J.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite

Effect of p53 Gene Transfer and Cisplatin in a Peritonitis Carcinomatosa Model with p53-Deficient Ovarian Cancer Cells

By Kigawa J.   Sato S.   Shimada M.   Kanamori Y.   Itamochi H.   Terakawa N.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 210-215

Elsevier

Access to resources Recommend Favorite

Detection of the TP53 Tumour Suppressor Gene Product and p53 Auto-antibodies in the Ascites of Women with Ovarian Cancer

By Angelopoulou K.   Diamandis E.P.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite

p53 And related proteins in epithelial ovarian cancer

By Sengupta P.S.   McGown A.T.   Bajaj V.   Blackhall F.   Swindell R.   Bromley M.   Shanks J.H.   Ward T.   Buckley C.H.   Reynolds K.   Slade R.J.   Jayson G.C.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2317-2328

Elsevier

Access to resources Recommend Favorite